Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 4:26 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1537–1560 of 8,691 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Breast Cancer Lymphedema
Interventions: Immediate Lymphatic Reconstruction; Procedure
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 3
States / cities: Tampa, Florida

Conditions: Primary Open Angle Glaucoma, Pseudoexfoliative Glaucoma, Pigmentary Glaucoma
Interventions: Hydrus Microstent, iStent Trabecular Micro Bypass; Device
Lead sponsor: Ivantis, Inc.; Industry
Eligibility: 45 Years to 84 Years
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Irvine, California

Conditions: Crohn's Disease, Inflammatory Bowel Disease
Interventions: Corticosteroid; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Osteoarthritis of Hip
Interventions: ArCom® Polyethylene, ArComXL® Polyethylene; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: Not listed
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2020
U.S. locations: 3
States / cities: New Albany, Ohio • Plano, Texas • Oshkosh, Wisconsin

Conditions: Kidney Stone, Renal Stone, Urolithiasis
Interventions: SURE, Standard Ureteroscopy (Basketing); Device
Lead sponsor: Calyxo, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 11
States / cities: Phoenix, Arizona • Tucson, Arizona • Baltimore, Maryland + 7 more

Conditions: Depression, Postpartum
Interventions: Zuranolone; Drug
Lead sponsor: Biogen; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 305 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Woonsocket, Rhode Island

Conditions: Endometrial Cancer
Interventions: Not listed
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years to 85 Years · Female only
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Opioid-Related Disorders, Opiate Addiction, Narcotic Abuse, Drug Abuse
Interventions: Observation Only; Other
Lead sponsor: Member Companies of the Opioid PMR Consortium; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 3,600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 2
States / cities: Portland, Oregon • Seattle, Washington

Conditions: Post-Traumatic Stress Disorders
Interventions: transcranial magnetic stimulation; Device
Lead sponsor: White River Junction Veterans Affairs Medical Center; Federal
Eligibility: 18 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 1
States / cities: White River Junction, Vermont

Conditions: Smoking Cessation
Interventions: placebo, varenicline; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 659 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 12
States / cities: Litchfield Park, Arizona • Los Angeles, California • Santa Ana, California + 9 more

Conditions: Atrial Fibrillation - Symptomatic
Interventions: Radiofrequency ablation; Procedure
Lead sponsor: Ohad Ziv; Other
Eligibility: 18 Years to 85 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Diabetic Foot Ulcer
Interventions: Tenex TXB MicroTip Ultrasound system plus SOC, Standard of Care for diabetic foot ulcer; Device · Other
Lead sponsor: Tenex Health Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 148 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 2
States / cities: Mobile, Alabama • St. George, Utah

Conditions: Biliary Atresia
Interventions: Filgrastim; Drug
Lead sponsor: Holterman, Ai-Xuan, M.D.; Individual
Eligibility: 14 Days to 180 Days
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Melasma
Interventions: PiQo4; Device
Lead sponsor: Focus Medical, LLC; Industry
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Hackensack, New Jersey

Conditions: Intestinal Disease
Interventions: Neostigmine Injectable Solution, Sugammadex injection; Drug
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Orange, California

Conditions: Scars, Scleroderma
Interventions: Laser Treatment; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Mitochondrial Disease
Interventions: Not listed
Lead sponsor: National Human Genome Research Institute (NHGRI); NIH
Eligibility: 2 Months to 115 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2099
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Hepatocellular Carcinoma, Cirrhosis
Interventions: Namenda; Drug
Lead sponsor: Inova Health Care Services; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 2
States / cities: Fairfax, Virginia • Falls Church, Virginia

Conditions: Osteoarthritis, Knee
Interventions: Navio™ Robotics-assisted Surgical System; Device
Lead sponsor: Columbia University; Other
Eligibility: 40 Years to 85 Years
Enrollment: 99 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Arthropathy Shoulder
Interventions: Liposomal Bupivacaine, Bupivacaine Hydrochloride; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Hematologic Malignancy, Bone Marrow Transplant
Interventions: Tocilizumab, Fludarabine, Melphalan, Anti-thymocyte globulin (rabbit), Total Body Irradiation; Drug · Radiation
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Raynaud's Disease
Interventions: onabotulinum toxin type-A; Drug
Lead sponsor: Southern Illinois University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Springfield, Illinois

Conditions: Asthma, Vitamin D Deficiency
Interventions: Vitamin D2 + vitamin D3, Vitamin D3; Drug
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: 8 Years to 17 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Innate Inflammatory Response, Vaccination, Diphtheria, Tetanus, Environmental Exposure, Vaccine, Antibodies, Adult, Immunity, Pollution; Exposure
Interventions: TENIVAC; Biological
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 89 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Paulsboro, New Jersey

Search by objective public record fields.

ILR to Prevent BRCL_MCC 23608

Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes

Corticosteroid Dosage for Crohn's Disease Flare

ArCom® and ArComXL® Polyethylene Data Collection

Comparison of Laser Lithotripsy With and Without Steerable Ureteroscopic Renal Evacuation (SURE)

A Study to Learn More About How Zuranolone Affects Postpartum Depression Symptoms in Participants Who Took it Within 1 Year After The End of Their Pregnancy

Study of Post Operative Pain in Endometrial Cancer Robotic Versus Laparotomy

A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Opioids for the Treatment of Chronic Pain

Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder

Randomized Study Comparing the Efficacy and Safety of Varenicline Tartrate to Placebo in Smoking Cessation When Subjects Are Allowed to Set Their Own Quit Date

Low Voltage-Directed Catheter Ablation for Atrial Fibrillation

Prospective, Multicenter, RCT of the Tenex Ultrasound System

Part II: Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia

Efficacy and Safety of PiQo4 Device for Treatment of Melasma

Neuromuscular Blockade Comparison for GI-2 Recovery After Bowel Resection

Laser Treatment for the Improvement of Scars and Scleroderma

Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity

A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer

Navio Robotic Versus Conventional Total Knee Arthroplasty

Liposomal Bupivacaine Interscalene Nerve Block in Shoulder Arthroplasty

Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation

A Two-Part Study of BOTOX® Therapy for Ischemic Digits

Vitamin D in Pediatric Asthma: a Randomized Controlled Open-label Pilot Trial

PFAS Exposure and Immune Response to Vaccination in Adults